Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Abacus Medicine

02 6Centocor

03 26Janssen-Cilag

04 43Johnson & Johnson Innovative Medicine

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

02

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

03

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

DARATUMUMAB

Brand Name : DARZALEX

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/5ML

Packaging :

Approval Date :

Application Number : 761036

Regulatory Info :

Registration Country : USA

blank

04

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

DARATUMUMAB

Brand Name : DARZALEX

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 400MG/20ML

Packaging :

Approval Date :

Application Number : 761036

Regulatory Info :

Registration Country : USA

blank

05

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

DARATUMUMAB AND HYALURONIDASE-FIHJ

Brand Name : DARZALEX FASPRO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG;2000UNITS/ML

Packaging :

Approval Date :

Application Number : 761145

Regulatory Info :

Registration Country : USA

blank

06

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumabum

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/5ml

Packaging :

Approval Date : 06/12/2016

Application Number : 66072

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumabum

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 400mg/20ml

Packaging :

Approval Date : 06/12/2016

Application Number : 66072

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumabum

Brand Name : DARZALEX SC

Dosage Form : Solution For Injection

Dosage Strength : 1800mg/15ml

Packaging :

Approval Date : 13/08/2020

Application Number : 67689

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 19-11-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

10

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date : 19-11-2020

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

11

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex®

Dosage Form : Injectable Solution

Dosage Strength :

Packaging :

Approval Date : 03-02-2025

Application Number :

Regulatory Info :

Registration Country : Moldova

blank

12

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Solution For Injection

Dosage Strength : 1800mg

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

13

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

14

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Marketed

Registration Country : Norway

blank

15

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Solution For Injection

Dosage Strength : 1800mg/15ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

16

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml; 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

17

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 20mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Estonia

blank

18

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 20MG

Packaging :

Approval Date : 24-09-2019

Application Number : 1161101002IP

Regulatory Info : Authorized

Registration Country : Spain

blank

19

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Injectable Solution

Dosage Strength : 1800MG

Packaging :

Approval Date : 15-06-2020

Application Number : 1161101004

Regulatory Info : Authorized

Registration Country : Spain

blank

20

BioProcess International US West
Not Confirmed
arrow
arrow
BioProcess International US West
Not Confirmed

Daratumumab

Brand Name : Darzalex

Dosage Form : Concentrate For Infusion Solution

Dosage Strength : 20MG

Packaging :

Approval Date : 08-01-2021

Application Number : 1161101001IP

Regulatory Info : Authorized

Registration Country : Spain

blank